Table 1 Clinical Characteristics of Cohort 1
From: Effects of body mass index on the immune response within the first days after major stroke in humans
Variable | Patient Group (N = 40) | Control Group (N = 16) |
|---|---|---|
Age [Years, Mean ± SD] | 71 ± 14 | 71 ± 8 |
Sex [as % female] | 55% | 44% |
BMI [Mean ± SD] | 28.45 ± 5.13 | 27.30 ± 3.42 |
First MRI Liver fat [%, Mean ± SD] | 8.30% ± 2.76 | 13.18 ± 8.15 |
Second MRI Liver fat [%, Mean ± SD] | 7.85% ± 2.40 | NA$ |
Weight Categories | ||
Obese [n (%)] | 15 (37.5) | 3 (18.8) |
Overweight [n (%)] | 14 (35.0) | 9 (56.3) |
Normal [n (%)] | 11 (27.5) | 6 (15.0) |
Comorbidities | ||
Hypertension [n (%)] | 31 (77.5) | 8 (50) |
Diabetes mellitus [n (%)] | 6 (15) | 5 (31.9) |
Stroke Characteristics | ||
Etiology | ||
Large-artery atherosclerosis | 10 (25) | NA$ |
Cardioembolism [n (%)] | 19 (47.5) | NA$ |
Stroke of other determined etiology [n (%)] | 2 (5) | NA$ |
Stroke of undetermined etiology [n (%)] | 9 (22.5) | NA$ |
First MRI Stroke Size [ml3, Median (IQR)] | 31.0 (7.5–78.0) | NA$ |
Second MRI Stroke Size [ml3, Median (IQR)] | 41.2 (8.2–89.6) | NA$ |
Initial NIHSS score [Median (IQR)] | 15 (11.25-21.00) | NA$ |
Infarct size [n (%), left-sided infarcts] | 20 (50.0) | NA$ |
Treatment [n (%)] | 30 (75.0) | NA$ |
Systemic thrombolysis [n (%)]& | 25 (62.5) | NA$ |
Mechanical thrombectomy [n (%)]& | 18 (45.0) | NA$ |
Combined treatment [n (%)] | 13 (32.5) | NA$ |